GILD Gilead Sciences, Inc. Shares Gain on News of HIV Drug Approval and Chaikin Power Gauge Bullish
The Chaikin Power Gauge RatingTM for Gilead Sciences, Inc. GILD is bullish due to very strong earnings performance and attractive financial metrics. The rating also reflects bearish price/volume activity.
GILD's earnings performance is very strong as a result of high earnings growth over the past 3-5 years and consistent earnings over the past 5 years.
Marc Chaikin is a recognized expert in stock market analysis. He developed computerized stock selection models for professional money managers as well as for individual investors. In addition, he pioneered and created the first real-time analytics workstation for portfolio managers and stock traders; his proprietary analytics are now part of Thomson Reuters’ institutional workstation.
Marc also created the widely-used Chaikin Oscillator and Chaikin Persistency of Money Flow, the basis of Investor’s Business Daily’s Accumulation/Distribution Rating. His indicators’ predictive value has made them de facto standards in most technical analysis software packages.